Better Coronavirus Stock: AstraZeneca vs. Eli Lilly
Several big pharma companies shifted into high gear soon after the novel coronavirus emerged as a serious health concern earlier this year. Some of them focused on COVID-19 vaccine development. Others focused on developing potential treatments for the viral disease.
AstraZeneca (NYSE: AZN) is a great example of the former group, while Eli Lilly (NYSE: LLY) stands out as a top drugmaker in the latter category. For investors, Lilly has been the bigger winner so far this year. But which of these coronavirus-focused pharma stocks is the better pick now?
Image source: Getty Images.
Source Fool.com
